AST5902 mesylate
AST5902 mesylate is the active metabolite of Furmonertinib (HY-112870) with antitumor activity, and acts as a EGFR inhibitor. AST5902 mesylate inhibits CYP3A4 mRNA transcription at low concentrations and induces CYP3A4 mRNA expression at high concentrations. AST5902 mesylate can be used in research related to non-small cell lung cancer.
For research use only. We do not sell to patients.
- CAS No.: 2412155-75-8
- Formula: C28H33F3N8O5S
- Molecular Weight:650.67
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All EGFR Isoforms
More
Biological Activity
Description
IC50 & Target
|
CYP3A4 |
EGFR |
In Vitro
AST5902 exhibits anti-tumor activity comparable to that of its parent compound Furmonertinib (HY-112870), a potent EGFR inhibitor.[1]
AST5902 is generated via CYP3A4-mediated N-demethylation of Furmonertinib in human liver microsomes[2].
AST5902 (0.003‑5 μM) modulates CYP3A4 mRNA expression in primary human hepatocytes, exhibiting weak to moderate CYP3A4 induction activity with an EC50 ranging from 0.13‑0.68 μM, and inhibits CYP3A4 mRNA transcription at low concentrations[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2412155-75-8
-
Molecular Weight 650.67
-
Formula C28H33F3N8O5S
-
SMILES
C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OCC(F)(F)F)N=C1N(C)CCNC)=O.O=S(O)(C)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)